Fresenius Kabi’s Generic Drugs Business Unit Head elected as president of Medicines for Europe

October 10, 2017

Fresenius Kabi’s Executive Vice President Business Unit Generic Drugs, Dr. Marc-Alexander Mahl, has been elected president of the Medicines for Europe association, a two year role. Medicines for Europe represents the generic, biosimilar and value added medicines industries across Europe.

For more information, please visit